you are here:
Success
Alert
Please select a Day.
Info
84.70
-1.15 (-1.34%)

As on 11 May, 2021 | 03:25

Trade
Day Range
83.65
89.90
L H
52 Week Range
34.55
95.75
L H
Volume
1,285,692
*
i

* BSE Market Depth (11 May 2021)

BUY SELL
QTY PRICE PRICE QTY
25 85.45 85.70 100
19 85.25 86.15 1700
260 85.15 86.25 280
704 85.10 86.50 75
10 85.05 86.70 500
33203 Total Total 92843
Bid / Ask
85.45 / 85.70
84.90
-1.05 (-1.22%)

As on 11 May, 2021 | 03:25

Day Range
82.30
89.40
L H
52 Week Range
34.95
95.85
L H
Volume
192,897
*
i

* BSE Market Depth (11 May 2021)

BUY SELL
QTY PRICE PRICE QTY
25 85.45 85.70 100
19 85.25 86.15 1700
260 85.15 86.25 280
704 85.10 86.50 75
10 85.05 86.70 500
33203 Total Total 92843
Bid / Ask
85.45 / 85.70
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Note :Financial Information is based on standalone numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open84.30
          Previous Close85.85
          UC Limit103.00
          LC Limit68.70
          Volume1,285,692.00
          VWAP86.49
          Mkt Cap (Rs. Cr.)776
          20D Avg Volume2,617,009
          20D Avg Delivery670,253
          Beta0.920.84
          Face Value10.00
          TTM EPS--
          TTM PE--
          Sector PE83.68
          Book Value Per Share--
          P/B0.00
          Dividend Yield0.00
          P/C--

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 147.47% away from 52 week low
          • 10.8% away from 52 week high
          • Outperformer - Indraprastha Medical Corporation up by 44.1% v/s NIFTY 50 up by 0.1% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          6

          indicates Average Financials

          3 year CAGR growth
          Revenue 2.8%
          NetProfit 18.5%
          OperatingProfit 3.1%
          Industry Comparison
          • TTM PE Ratio - Negative PE Trailing 12M
          • Market Cap - Below industry Median
          • Price to Book Ratio - Above industry Median
          • TTM PEG Ratio - Market Runner Up
          Shareholding Pattern
          • Promoters holding remains unchanged at 51.0% in Mar 2021 qtr
          • Institutional Investors holding remains unchanged at 0.02% in Mar 2021 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          Forum

          Community Sentiments

          • 75% BUY
          • 25% SELL
          • 0% HOLD
          75%
          of moneycontrol users recommend buying Indraprastha

          What's your call on Indraprastha today?

          Read 4 investor views

          BUY SELL HOLD

          Broker Research

          12 Mar, 2021

          Sharekhan

          Reco Price 53.50 Target Price 650
          12 Feb, 2021

          ICICIdirect.com

          Reco Price 52.40 Target Price 595
          11 Feb, 2021

          Dolat Capital

          Reco Price 52.80 Target Price 631
          10 Feb, 2021

          Sharekhan

          Reco Price 53.05 Target Price 650
          01 Jan, 2021

          Sharekhan

          Reco Price 57.35 Target Price 585
          13 Nov, 2020

          ICICIdirect.com

          Reco Price 49.30 Target Price 430

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          06 May, 2021

          GRAVITON RESEARCH CAPITAL LLP

          Qty 1358056 Price 91.02 % Traded 1.48
          06 May, 2021

          NK SECURITIES RESEARCH PRIVATE LIMITED

          Qty 657703 Price 90.76 % Traded 0.72
          06 May, 2021

          QE SECURITIES

          Qty 638265 Price 91.21 % Traded 0.70
          06 May, 2021

          XTX MARKETS LLP

          Qty 589560 Price 90.41 % Traded 0.64
          06 May, 2021

          GRAVITON RESEARCH CAPITAL LLP

          Qty 1358056 Price 91.09 % Traded 1.48
          06 May, 2021

          NK SECURITIES RESEARCH PRIVATE LIMITED

          Qty 657703 Price 90.83 % Traded 0.72
          06 May, 2021

          QE SECURITIES

          Qty 638303 Price 91.25 % Traded 0.70
          06 May, 2021

          XTX MARKETS LLP

          Qty 593161 Price 90.5 % Traded 0.65

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          No Data For Insider Transaction Summary.

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Dec, 28, 2015

          Housing Development Finance Corporation Ltd

          Other
          Qty 1944420 Price 0 % Traded 2.12 Post Tnx Hold. 7.69%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Indraprastha 85.60 -0.29 784.72 - 2.93 16.28 121.76 43 830 0.01
          Apollo Hospital 3266.00 -1.74 46960.07 232.62 13.54 13.62 150.42 434 11,246 1.00
          Dr Lal PathLab 2832.00 -2.15 23603.27 98.06 22.39 21.86 82.31 227 1,330 0.00
          Max Healthcare 233.50 0.86 22554.82 - 8.02 2.23 - 26 1,134 0.65
          Fortis Health 236.40 0.83 17847.21 - 2.48 0.86 89.88 79 4,632 0.20

          About the Company

          Indraprastha Medical Corpn. Ltd offers a range of diagnostic, medical, and surgical facilities for the care of their patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology, neurology, orthopedics, nephrology, ophthalmology, nuclear medicine, pediatrics, physiotherapy and rehabilitation, psychiatry and psychology, radiology, urology and andrology, gastroenterology, gynecology and obstetrics, dermatology, dietetics and nutrition, and respiratory and sleep medicine. The hospital also offers various surgical services, including dental, cardiothoracic, neuro, vascular, joint, plastic and cosmetic, and general surgeries. In addition, the companys diagnostic services include lab services, radio-diagnosis, nuclear medicine, endoscopy lab, bronchoscopy lab, and blood bank. Further, the hospital offers ambulance and air ambulance services, as well as out patient consultation services.The company also plans to set up more than ten satellite clinics in and around Delhi to facilitate easy availability of Apollo-type medical services to a larger cross-section of society. These clinics are to take the shape of mini-hospitals with all basic back-up emergency services mainly aimed at providing post-treatment facilities to Apollo Hospitals patients.
          {"success":1,"data":{"address":{"address1":"Sarita Vihar,","address2":"Delhi-Mathura Road,,","city":"New Delhi","state":"Delhi","pincode":"110076","telephone1":"011-26925858","telephone2":"011-26925801","fax1":"011-26823629","fax2":"","email":"imclshares@apollohospitalsdelhi.com","web":"http:\/\/www.apollohospdelhi.com"},"management":[{"name":"Prathap C Reddy","designation":"Vice Chairman"},{"name":"P Shivakumar","designation":"Managing Director"},{"name":"Arun Rai","designation":"Director"},{"name":"Deepak Vaidya","designation":"Director"},{"name":"Satnam Arora","designation":"Director"}],"registrars":{"name":"Link Intime India Pvt. Ltd.","address1":"Noble Heights, Ist Floor, \nPlot NH 2, C-1 Block LS","address2":"","address3":"","address4":"","telephone":"011-49411000","fax":"011-41410591","email":"delhi@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"New Delhi","state":"Delhi","pincode":"110058"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"532150","nseId":"INDRAMEDCO","series":"EQ","isinid":"INE681B01017"}}}
          • Registered Office

          • Registrars

          • Management

            • Prathap C Reddy

              Vice Chairman

            • P Shivakumar

              Managing Director

            • Arun Rai

              Director

            • Deepak Vaidya

              Director

            • Satnam Arora

              Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              532150

            • NSE:

              INDRAMEDCO

            • Series

              EQ

            • ISIN

              INE681B01017

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>